Literature DB >> 26738364

Impaired cognitive performance and hippocampal atrophy in Parkinson disease.

Demet Yildiz, Sevda Erer, Mehmet Zarifoğlu, Bahattin Hakyemez, Mustafa Bakar, Necdet Karli, Zeynep Nigar Varlibaş, Fatih Tufan.   

Abstract

BACKGROUND/AIM: Dementia is common in Parkinson disease (PD). Since magnetic resonance imaging has been used, hippocampal atrophy has been shown in PD patients with or without dementia. In this study we sought the correlation of cognitive decline with bilateral hippocampal volume in PD patients.
MATERIALS AND METHODS: Thirty-three patients with diagnosis of idiopathic PD and 16 healthy subjects were included in this study. PD patients were divided into two groups as normal cognitive function and mild cognitive impairment (MCI). The Mini-Mental State Examination and detailed cognitive assessment tests were performed for all patients for cognitive analyses. Depression was excluded by the Geriatric Depression Scale.
RESULTS: The mean onset age of disease was 55 years for PD patients without dementia and 59 for PD patients with MCI. According to the Hoehn-Yahr scales, 24% of patients had grade 1, 58% had grade 2, and 18% had grade 3 disease. Right and left hippocampal volumes decreased along with cognitive test scores in PD patients. Increased right hippocampal volume was correlated with forward number test in the MCI-PD group.
CONCLUSION: These findings suggest that memory deficit is associated with hippocampal atrophy in PD patients.

Entities:  

Mesh:

Year:  2015        PMID: 26738364     DOI: 10.3906/sag-1408-68

Source DB:  PubMed          Journal:  Turk J Med Sci        ISSN: 1300-0144            Impact factor:   0.973


  7 in total

Review 1.  Cognitive decline in Parkinson disease.

Authors:  Dag Aarsland; Byron Creese; Marios Politis; K Ray Chaudhuri; Dominic H Ffytche; Daniel Weintraub; Clive Ballard
Journal:  Nat Rev Neurol       Date:  2017-03-03       Impact factor: 42.937

2.  Brain connectivity markers in advanced Parkinson's disease for predicting mild cognitive impairment.

Authors:  Hai Lin; Zesi Liu; Wei Yan; Doudou Zhang; Jiali Liu; Bin Xu; Weiping Li; Qiusheng Zhang; Xiaodong Cai
Journal:  Eur Radiol       Date:  2021-06-09       Impact factor: 5.315

3.  Selegiline Recovers Synaptic Plasticity in the Medial Prefrontal Cortex and Improves Corresponding Depression-Like Behavior in a Mouse Model of Parkinson's Disease.

Authors:  Motoki Okano; Kazue Takahata; Junya Sugimoto; Shizuko Muraoka
Journal:  Front Behav Neurosci       Date:  2019-08-02       Impact factor: 3.558

4.  Hydrogen Sulfide Attenuates the Cognitive Dysfunction in Parkinson's Disease Rats via Promoting Hippocampal Microglia M2 Polarization by Enhancement of Hippocampal Warburg Effect.

Authors:  Qing Tian; Hui-Ling Tang; Yi-Yun Tang; Ping Zhang; Xuan Kang; Wei Zou; Xiao-Qing Tang
Journal:  Oxid Med Cell Longev       Date:  2022-01-04       Impact factor: 6.543

Review 5.  Experimental Models of Cognitive Impairment for Use in Parkinson's Disease Research: The Distance Between Reality and Ideal.

Authors:  Yaohua Fan; Jiajun Han; Lijun Zhao; Chunxiao Wu; Peipei Wu; Zifeng Huang; Xiaoqian Hao; YiChun Ji; Dongfeng Chen; Meiling Zhu
Journal:  Front Aging Neurosci       Date:  2021-11-29       Impact factor: 5.750

6.  Semantic Integration of Multi-Modal Data and Derived Neuroimaging Results Using the Platform for Imaging in Precision Medicine (PRISM) in the Arkansas Imaging Enterprise System (ARIES).

Authors:  Jonathan Bona; Aaron S Kemp; Carli Cox; Tracy S Nolan; Lakshmi Pillai; Aparna Das; James E Galvin; Linda Larson-Prior; Tuhin Virmani; Fred Prior
Journal:  Front Artif Intell       Date:  2022-02-10

7.  Mild Cognitive Impairment Subtypes Are Associated With Peculiar Gait Patterns in Parkinson's Disease.

Authors:  Marianna Amboni; Carlo Ricciardi; Sofia Cuoco; Leandro Donisi; Antonio Volzone; Gianluca Ricciardelli; Maria Teresa Pellecchia; Gabriella Santangelo; Mario Cesarelli; Paolo Barone
Journal:  Front Aging Neurosci       Date:  2022-03-01       Impact factor: 5.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.